The Management of Pain in Children with Life-limiting Illnesses

Pediatric Clinics of North America

Volumn 54, Issue 5, 2007, Pages 645-672

  Friedrichsdorf, Stefan J ^a   Kang, Tammy I ^b  

^a CHILDREN S HOSPITALS AND CLINICS OF MINNESOTA   (United States)

^b CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CODEINE; CODEINE 6 GLUCURONIDE; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DELTA OPIATE RECEPTOR; EPSILON OPIATE RECEPTOR; ERYTHROMYCIN; FENTANYL; HYDROCODONE; HYDROMORPHONE; KAPPA OPIATE RECEPTOR; KETOCONAZOLE; METHADONE; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; MU OPIATE RECEPTOR; NALOXONE; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; NORCODEINE; OPIATE; OXYCODONE; PARACETAMOL; PROTEINASE INHIBITOR; RITONAVIR; SEROTONIN; SIGMA OPIATE RECEPTOR; TRAMADOL; UNINDEXED DRUG;

ALLODYNIA; ANALGESIA; ANTINOCICEPTION; CHILD CARE; CONFUSION; CONSTIPATION; DISEASE SEVERITY; DRUG CHOICE; DRUG DEPENDENCE; DRUG DOSE TITRATION; DRUG ELIMINATION; DRUG HALF LIFE; DRUG MEGADOSE; DRUG METABOLISM; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FATIGUE; HUMAN; HYPERALGESIA; MYOCLONUS; NAUSEA; NEUROMODULATION; NEUROPATHIC PAIN; NOCICEPTION; PAIN; PAIN ASSESSMENT; PALLIATIVE THERAPY; PATHOPHYSIOLOGY; PRURITUS; RECOMMENDED DRUG DOSE; RESPIRATION DEPRESSION; REVIEW; TERMINAL DISEASE; TREATMENT INDICATION; TREATMENT PLANNING; URINE RETENTION; VOMITING;

ANALGESICS, OPIOID; CHILD; CHRONIC DISEASE; CODEINE; FENTANYL; HUMANS; HYDROMORPHONE; KETAMINE; METHADONE; MORPHINE; NOCICEPTORS; OXYCODONE; PAIN; PAIN MEASUREMENT; SEVERITY OF ILLNESS INDEX;

EID: 35148882590     PISSN: 00313955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pcl.2007.07.007     Document Type: Review

References (101)

1. Albano E.A., and Odom L.F. Supportive care in pediatric oncology. Curr Opin Pediatr 5 (1993) 131
2. Contro N., Larson J., Scofield S., et al. Family perspectives on the quality of pediatric palliative care. Arch Pediatr Adolesc Med 156 (2002) 14
3. Drake R., Frost J., and Collins J.J. The symptoms of dying children. J Pain Symptom Manage 26 (2003) 594
4. Goldman A., Hewitt M., Collins G.S., et al. Symptoms in children/young people with progressive malignant disease: United Kingdom Children's Cancer Study Group/Paediatric Oncology Nurses Forum survey. Pediatrics 117 (2006) e1179
5. Jalmsell L., Kreicbergs U., Onelov E., et al. Symptoms affecting children with malignancies during the last month of life: a nationwide follow-up. Pediatrics 117 (2006) 1314
6. Wolfe J., Grier H.E., Klar N., et al. Symptoms and suffering at the end of life in children with cancer. N Engl J Med 342 (2000) 326
7. Carter B.S., Howenstein M., Gilmer M.J., et al. Circumstances surrounding the deaths of hospitalized children: opportunities for pediatric palliative care. Pediatrics 114 (2004) e361
8. Schechter N.L. The undertreatment of pain in children: an overview. Pediatr Clin North Am 36 (1989) 781
9. Brown Jr. R.E., Schmitz M.L., and Andelman P.D. The treatment of pain in children. J Ark Med Soc 90 (1993) 112
10. Mack J.W., Hilden J.M., Watterson J., et al. Parent and physician perspectives on quality of care at the end of life in children with cancer. J Clin Oncol 23 (2005) 9155
11. Ellis J.A., McCarthy P., Hershon L., et al. Pain practices: a cross-Canada survey of pediatric oncology centers. J Pediatr Oncol Nurs 20 (2003) 26
12. Hilden J.M., Emanuel E.J., Fairclough D.L., et al. Attitudes and practices among pediatric oncologists regarding end-of-life care: results of the 1998 American Society of Clinical Oncology survey. J Clin Oncol 19 (2001) 205
13. Fausett H. Anatomy and physiology of pain. In: Carol A., and Warfield Z.H.B. (Eds). Principles and practice of pain medicine. 2nd edition (2004), McGraw Hill, New York 28
14. McGrath P.A. Development of the World Health Organization Guidelines on cancer pain relief and palliative care in children. J Pain Symptom Manage 12 (1996) 87
15. Ventafridda V., Saita L., Ripamonti C., et al. WHO guidelines for the use of analgesics in cancer pain. Int J Tissue React 7 (1985) 93
16. Zech D.F., Grond S., Lynch J., et al. Validation of World Health Organization guidelines for cancer pain relief: a 10-year prospective study. Pain 63 (1995) 65
17. Babul N., and Darke A.C. Evaluation and use of opioid analgesics in pediatric cancer pain. J Palliat Care 9 (1993) 19
18. Caraceni A., Cherny N., Fainsinger R., et al. Pain measurement tools and methods in clinical research in palliative care: recommendations of an Expert Working Group of the European Association of Palliative Care. J Pain Symptom Manage 23 (2002) 239
19. Clark J.L., and Kalan G.E. Effective treatment of severe cancer pain of the head using low-dose ketamine in an opioid-tolerant patient. J Pain Symptom Manage 10 (1995) 310
20. Ducharme J. Acute pain and pain control: state of the art. Ann Emerg Med 35 (2000) 592
21. Franck L.S., Greenberg C.S., and Stevens B. Pain assessment in infants and children. Pediatr Clin North Am 47 (2000) 487
22. Greco C., and Berde C. Pain management for the hospitalized pediatric patient. Pediatr Clin North Am 52 (2005) 995
23. Choi Y.S., and Billings J.A. Opioid antagonists: a review of their role in palliative care, focusing on use in opioid-related constipation. J Pain Symptom Manage 24 (2002) 71
24. Inturrisi C.E. Clinical pharmacology of opioids for pain. Clin J Pain 18 (2002) S3
25. Zichterman A. Opioid pharmacology and considerations in pain management. In: Pharmacist U; 2007. Available at: https://www.uspharmacist.com/index.asp?page=ce/105473/default.htm. Accessed September 17, 2007.
26. Armstrong S.C., and Cozza K.L. Pharmacokinetic drug interactions of morphine, codeine, and their derivatives: theory and clinical reality, Part II. Psychosomatics 44 (2003) 515
27. Cohen S. Pathophysiology of pain. In: Warfield C., and Bajwa Z. (Eds). Principles and practices of pain medicine. 2nd edition (2004), McGraw-Hill, New York
28. Dampier C.D., Setty B.N., Logan J., et al. Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr 126 (1995) 461
29. Koren G., and Maurice L. Pediatric uses of opioids. Pediatr Clin North Am 36 (1989) 1141
30. Hunt A., Joel S., Dick G., et al. Population pharmacokinetics of oral morphine and its glucuronides in children receiving morphine as immediate-release liquid or sustained-release tablets for cancer pain. J Pediatr 135 (1999) 47
31. Hunt R., Fazekas B., Thorne D., et al. A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manage 18 (1999) 111
32. Lugo R.A., and Kern S.E. Clinical pharmacokinetics of morphine. J Pain Palliat Care Pharmacother 16 (2002) 5
33. Smith M.T. Neuroexcitatory effects of morphine and hydromorphone: evidence implicating the 3-glucuronide metabolites. Clin Exp Pharmacol Physiol 27 (2000) 524
34. Chang S.F., Moore L., and Chien Y.W. Pharmacokinetics and bioavailability of hydromorphone: effect of various routes of administration. Pharm Res 5 (1988) 718
35. Babul N., Darke A.C., and Hagen N. Hydromorphone metabolite accumulation in renal failure. J Pain Symptom Manage 10 (1995) 184
36. Babul N., Darke A.C., and Hain R. Hydromorphone and metabolite pharmacokinetics in children. J Pain Symptom Manage 10 (1995) 335
37. Dean M. Opioids in renal failure and dialysis patients. J Pain Symptom Manage 28 (2004) 497
38. Doyle L., and Colletti J.E. Pediatric procedural sedation and analgesia. Pediatr Clin North Am 53 (2006) 279
39. Noyes M., and Irving H. The use of transdermal fentanyl in pediatric oncology palliative care. Am J Hosp Palliat Care 18 (2001) 411
40. Collins C., Koren G., Crean P., et al. Fentanyl pharmacokinetics and hemodynamic effects in preterm infants during ligation of patent ductus arteriosus. Anesth Analg 64 (1985) 1078
41. Collins J.J., Dunkel I.J., Gupta S.K., et al. Transdermal fentanyl in children with cancer pain: feasibility, tolerability, and pharmacokinetic correlates. J Pediatr 134 (1999) 319
42. Zernikow B., Michel E., and Anderson B. Transdermal fentanyl in childhood and adolescence: a comprehensive literature review. J Pain 8 (2007) 187
43. Kokki H., Rasanen I., Reinikainen M., et al. Pharmacokinetics of oxycodone after intravenous, buccal, intramuscular and gastric administration in children. Clin Pharmacokinet 43 (2004) 613
44. Lugo R.A., and Kern S.E. The pharmacokinetics of oxycodone. J Pain Palliat Care Pharmacother 18 (2004) 17
45. Sharar S.R., Carrougher G.J., Selzer K., et al. A comparison of oral transmucosal fentanyl citrate and oral oxycodone for pediatric outpatient wound care. J Burn Care Rehabil 23 (2002) 27
46. Taketomo C, Hodding J, Kraus D. Pediatric Dosage Handbook. 13th edition. Hudson (NH): 2006.
47. Tobias J.D. Weak analgesics and nonsteroidal anti-inflammatory agents in the management of children with acute pain. Pediatr Clin North Am 47 (2000) 527
48. Shir Y., Eimerl D., Magora F., et al. Plasma concentrations of methadone during postoperative patient-controlled extradural analgesia. Br J Anaesth 65 (1990) 204
49. Shir Y., Rosen G., Zeldin A., et al. Methadone is safe for treating hospitalized patients with severe pain. Can J Anaesth 48 (2001) 1109
50. Shir Y., Shenkman Z., Shavelson V., et al. Oral methadone for the treatment of severe pain in hospitalized children: a report of five cases. Clin J Pain 14 (1998) 350
51. Subramaniam K., Subramaniam B., and Steinbrook R.A. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg 99 (2004) 482
52. Berde C.B., Beyer J.E., Bournaki M.C., et al. Comparison of morphine and methadone for prevention of postoperative pain in 3- to 7-year-old children. J Pediatr 119 (1991) 136
53. Brown R., Kraus C., Fleming M., et al. Methadone: applied pharmacology and use as adjunctive treatment in chronic pain. Postgrad Med J 80 (2004) 654
54. Drake R., and Hain R. Pain-pharmacological management (2006), Oxford University Press, New York
55. Drake R., Longworth J., and Collins J.J. Opioid rotation in children with cancer. J Palliat Med 7 (2004) 419
56. Theunissen J.M., Hoogerbrugge P.M., van Achterberg T., et al. Symptoms in the palliative phase of children with cancer. Pediatr Blood Cancer 49 (2007) 160
57. Cherny N., Ripamonti C., Pereira J., et al. Strategies to manage the adverse effects of oral morphine: an evidence-based report. J Clin Oncol 19 (2001) 2542
58. Kronenberg R.H. Ketamine as an analgesic: parenteral, oral, rectal, subcutaneous, transdermal and intranasal administration. J Pain Palliat Care Pharmacother 16 (2002) 27
59. Berde C.B., Lebel A., and Olsson G. Neuropathic pain in children. In: Schechter N.L., Berde C., and Yaster M. (Eds). Pain in infants, children, and adolescents. 2nd edition (2003), Lippincott Williams & Williams, Philadelphia 620
60. Faulkner K.W., Thayer P.B., Coulter D.L., et al. Algorithm for neuropathic pain treatment: an evidence based proposal. Pain 118 (2005) 289
61. Collins J.J., Berde C.B., Grier H.E., et al. Massive opioid resistance in an infant with a localized metastasis to the midbrain periaqueductal gray. Pain 63 (1995) 271
62. Collins J.J., Grier H.E., Kinney H.C., et al. Control of severe pain in children with terminal malignancy. J Pediatr 126 (1995) 653
63. Siden H. Nalewajek. High dose opioids in pediatric palliative care. J Pain Symptom Manage 25 (2003) 397
64. Hocking G, Visser EJ, Schug SA, et al. Ketamine: does life begin at 40? In: Pain Clinical Updates International Association for the Study of Pain, vol. 15(3); 2007. p. 1.
65. Aspinall R.L., and Mayor A. A prospective randomized controlled study of the efficacy of ketamine for postoperative pain relief in children after adenotonsillectomy. Paediatr Anaesth 11 (2001) 333
66. Finkel J.C., Pestieau S.R., and Quezado Z.M. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents. J Pain 8 (2007) 515
67. Klepstad P., Borchgrevink P., Hval B., et al. Long-term treatment with ketamine in a 12-year-old girl with severe neuropathic pain caused by a cervical spinal tumor. J Pediatr Hematol Oncol 23 (2001) 616
68. Laufer M., Schippel P., Wild L., et al. [Treatment of extreme tumour pain with morphine and s-ketamine A case report of an 11-year old girl]. Schmerz 19 (2005) 220 [in German]
69. Marcus R.J., Victoria B.A., Rushman S.C., et al. Comparison of ketamine and morphine for analgesia after tonsillectomy in children. Br J Anaesth 84 (2000) 739
70. Tsui B.C., Davies D., Desai S., et al. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma. J Pediatr Hematol Oncol 26 (2004) 678
71. Dix P., Martindale S., and Stoddart P.A. Double-blind randomized placebo-controlled trial of the effect of ketamine on postoperative morphine consumption in children following appendicectomy. Paediatr Anaesth 13 (2003) 422
72. Bell R., Eccleston C., and Kalso E. Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 1 (2003) CD003351
73. McQuay H.J., Tramer M., Nye B.A., et al. A systematic review of antidepressants in neuropathic pain. Pain 68 (1996) 217
74. Chiu Y.K., Prendiville J.S., Bennett S.M., et al. Pain management of junctional epidermolysis bullosa in an 11-year-old boy. Pediatr Dermatol 16 (1999) 465
75. Collins J.J., Kerner J., Sentivany S., et al. Intravenous amitriptyline in pediatrics. J Pain Symptom Manage 10 (1995) 471
76. Guler N., Durmus E., and Tuncer S. Long-term follow-up of patients with atypical facial pain treated with amitriptyline. N Y State Dent J 71 (2005) 38
77. Lauder G.R., and White M.C. Neuropathic pain following multilevel surgery in children with cerebral palsy: a case series and review. Paediatr Anaesth 15 (2005) 412
78. Arvio M., and Merikanto J. [A relief from neural pain-gabapentin helped against hip ache in a girl with cerebral palsy]. Duodecim 117 (2001) 1447 [in Finnish]
79. Behm M.O., and Kearns G.L. Treatment of pain with gabapentin in a neonate. Pediatrics 108 (2001) 482
80. Butkovic D., Toljan S., and Mihovilovic-Novak B. Experience with gabapentin for neuropathic pain in adolescents: report of five cases. Paediatr Anaesth 16 (2006) 325
81. Gay C.T. An 8-year-old girl with unilateral facial and ear pain and isolated frontal headaches. Semin Pediatr Neurol 6 (1999) 182
82. Keskinbora K., Pekel A.F., and Aydinli I. The use of gabapentin in a 12-year-old boy with cancer pain. Acta Anaesthesiol Scand 48 (2004) 663
83. McGraw T., and Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology 86 (1997) 988
84. McGraw T., and Stacey B.R. Gabapentin for treatment of neuropathic pain in a 12-year-old girl. Clin J Pain 14 (1998) 354
85. Rusy L.M., Troshynski T.J., and Weisman S.J. Gabapentin in phantom limb pain management in children and young adults: report of seven cases. J Pain Symptom Manage 21 (2001) 78
86. Argoff C.E., Galer B.S., Jensen M.P., et al. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the neuropathic pain scale. Curr Med Res Opin 20 Suppl 2 (2004) S21
87. Davies P.S., and Galer B.S. Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia. Drugs 64 (2004) 937
88. Galer B.S., Jensen M.P., Ma T., et al. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 18 (2002) 297
89. Gammaitoni A.R., Galer B.S., Onawola R., et al. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the neuropathic pain scale. Curr Med Res Opin 20 Suppl 2 (2004) S13
90. Herrmann D.N., Barbano R.L., Hart-Gouleau S., et al. An open-label study of the lidocaine patch 5% in painful idiopathic sensory polyneuropathy. Pain Med 6 (2005) 379
91. Meier T., Faust M., Huppe M., et al. [Reduction of chronic pain for non-postherpetic peripheral neuropathies after topical treatment with a lidocaine patch]. Schmerz 18 (2004) 172 [in German]
92. Meier T., Wasner G., Faust M., et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain 106 (2003) 151
93. Rowbotham M.C., Davies P.S., and Verkempinck C. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65 (1996) 39
94. Hooke M.C., Grund E., Quammen H., et al. Propofol use in pediatric patients with severe cancer pain at the end of life. J Pediatr Oncol Nurs 24 (2007) 29
95. Faulkner K.W., Thayer P., and Coulter D.L. Neurological and neuromuscular symptoms. In: Goldman A., Hain R., and Liben S. (Eds). Oxford textbook of palliative care for children (2006), Oxford University Press, New York 409
96. Chen E., Joseph M.H., and Zeltzer L.K. Behavioral and cognitive interventions in the treatment of pain in children. Pediatr Clin North Am 47 (2000) 513
97. Poltorak D.Y., and Benore E. Cognitive-behavioral interventions for physical symptom management in pediatric palliative medicine. Child Adolesc Psychiatr Clin N Am 15 (2006) 683
98. Rusy L.M., and Weisman S.J. Complementary therapies for acute pediatric pain management. Pediatr Clin North Am 47 (2000) 589
99. Zeltzer L.K., Tsao J.C., Stelling C., et al. A phase I study on the feasibility and acceptability of an acupuncture/hypnosis intervention for chronic pediatric pain. J Pain Symptom Manage 24 (2002) 437
100. Beider S., and Moyer C.A. Randomized controlled trials of pediatric massage: a review. Evid Based Complement Alternat Med 4 (2007) 23
101. Tsao J.C., Meldrum M., Bursch B., et al. Treatment expectations for CAM interventions in pediatric chronic pain patients and their parents. Evid Based Complement Alternat Med 2 (2005) 521